Position
Chief Financial Officer
Company
Sparrow Pharmaceuticals
PortlandHealthcareHealth CareDescription
Sparrow Pharmaceuticals has appointed George Eldridge as their new chief financial officer (CFO). Mr. Eldridge brings extensive experience in biotechnology financial leadership.
Quick answer
Sparrow Pharmaceuticals Appoints George Eldridge as Chief Financial Officer (September 9, 2026). Sparrow Pharmaceuticals is based in Portland, Oregon, United States.
- Who is the new Chief Financial Officer at Sparrow Pharmaceuticals?
- Sparrow Pharmaceuticals named George Eldridge Chief Financial Officer, announced September 9, 2026.
- What did Sparrow Pharmaceuticals announce on September 9, 2026?
- Sparrow Pharmaceuticals has appointed George Eldridge as their new chief financial officer (CFO). Mr. Eldridge brings extensive experience in biotechnology financial leadership.
- What does Sparrow Pharmaceuticals do?
- Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such...
- Where is Sparrow Pharmaceuticals based?
- Sparrow Pharmaceuticals is based in Portland, Oregon, United States.
- Which similar companies made leadership changes around the same time?
- electroCore (September 9, 2026), Retension Pharmaceuticals (September 10, 2026), TransMedics Group (September 10, 2026) and Q32 Bio (September 14, 2026) also announced leadership changes within 45 days of Sparrow Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Health Care
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- electroCore Appoints Joshua Lev and Michael Fox as Co-CEOs (September 9, 2026)
- Retension Pharmaceuticals Appoints LeAnne Bloedon as EVP of Clinical Development (September 10, 2026)
- TransMedics Appoints Fernando Araujo as Chief Financial Officer (September 10, 2026)
- Q32 Bio Appoints José Trevejo as Chief Medical Officer and Ellie Hershberger as Chief Development Officer (September 14, 2026)
- Harrow, Inc. Appoints Andrew R. Boll as Principal Accounting Officer (September 4, 2026)
- LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer (September 15, 2026)
Who to call at Sparrow Pharmaceuticals, and when
A new leader at Sparrow Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Sparrow Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sparrow Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sparrow Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sparrow Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Sparrow Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.